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The networks that govern carbon metabolism and control intracellular carbon partitioning in photosynthetic cells are poorly
understood. Target of Rapamycin (TOR) kinase is a conserved growth regulator that integrates nutrient signals and
modulates cell growth in eukaryotes, though the TOR signaling pathway in plants and algae has yet to be completely
elucidated. We screened the unicellular green alga Chlamydomonas reinhardtii using insertional mutagenesis to ﬁnd mutants
that conferred hypersensitivity to the TOR inhibitor rapamycin. We characterized one mutant, vip1-1, that is predicted to
encode a conserved inositol hexakisphosphate kinase from the VIP family that pyrophosphorylates phytic acid (InsP6) to
produce the low abundance signaling molecules InsP7 and InsP8. Unexpectedly, the rapamycin hypersensitive growth arrest
of vip1-1 cells was dependent on the presence of external acetate, which normally has a growth-stimulatory effect on
Chlamydomonas. vip1-1mutants also constitutively overaccumulated triacylglycerols (TAGs) in a manner that was synergistic
with other TAG inducing stimuli such as starvation. vip1-1 cells had reduced InsP7 and InsP8, both of which are dynamically
modulated in wild-type cells by TOR kinase activity and the presence of acetate. Our data uncover an interaction between the
TOR kinase and inositol polyphosphate signaling systems that we propose governs carbon metabolism and intracellular
pathways that lead to storage lipid accumulation.
INTRODUCTION
Photosynthetic cells are deﬁned by their ability to ﬁx and me-
tabolize inorganic carbon (CO2 or HCO3
2). Many photosynthetic
organisms can also grow heterotrophically or mixotrophically
using externally supplied organic carbon or with a combination of
photosynthesis and imported organic carbon (Pringsheim and
Wiessner, 1960; Koch, 2004; Harris, 2009a; Morales-Sánchez
et al., 2015). Themeans by which photosynthetic cells coordinate
these two modes of carbon metabolism are relatively unexplored
(Sheen, 1994; Coruzzi and Bush, 2001; Halford and Paul, 2003;
Smith and Stitt, 2007), but the elucidation of intracellular carbon
regulatory networks has the potential to improve our un-
derstanding of photosynthetic cell growth and provide insights
that will allow harnessing of photosynthesis for improved yields
and storage of ﬁxed carbon.
The unicellular green alga Chlamydomonas reinhardtii is
a model organism that has been used successfully to dissect
and understand photosynthetic metabolism (Rochaix, 1995;
Grossman, 2000; Dent et al., 2005;Minagawa and Tokutsu, 2015;
Goodenough, 2015). Chlamydomonas cells can grow photo-
trophically and can also metabolize acetate and related com-
pounds to grow mixotrophically or heterotrophically. The
relationship between these modes of growth is complex and in-
volves partial suppression of photosynthesis and alterations in
gene expression when acetate is present (Heifetz et al., 2000;
Boyle and Morgan, 2009; Johnson and Alric, 2012; Roach et al.,
2013; Chapman et al., 2015). However, very little is known about
intracellular signaling pathways that sense carbon source and
control carbon metabolism and utilization in Chlamydomonas.
Target of Rapamycin (TOR) protein kinase is a conserved and
essential regulator of eukaryotic cell growth that is thought to
integrate external and internal metabolic cues to balance cell
growth with energy and nutrient supplies (Menand et al., 2002;
Loewith and Hall, 2011; Montané and Menand, 2013; Xiong and
Sheen, 2012; Xiong et al., 2013; Rexin et al., 2015). In yeast
andmetazoans, TOR is found in two different complexes, TORC1
and TORC2, with distinct functions in cell growth and cytoskeletal
organization, respectively, while green algae and land plants only
1Current Address: Instituto de Bioquímica Vegetal y Fotosíntesis, Seville
41092, Spain.
2 Current Address: University of Florida, Gainesville, FL 32611.
3 Current Address: Earth and Planetary Science, University of California,
Berkeley, CA 94720-4767.
4 Address correspondence to jumen@danforthcenter.org.
The author responsible for distribution of materials integral to the ﬁndings
presented in this article in accordance with the policy described in the
Instructions for Authors (www.plantcell.org) is: James G. Umen (jumen@
danforthcenter.org).
OPENArticles can be viewed without a subscription.
www.plantcell.org/cgi/doi/10.1105/tpc.16.00351
The Plant Cell, Vol. 28: 2026–2042, September 2016, www.plantcell.org ã 2016 American Society of Plant Biologists. All rights reserved.
contain the components of TORC1, namely, TOR, RAPTOR, and
LST8 (Díaz-Troya et al., 2008; Loewith and Hall, 2011; Moreau
et al., 2012; Maegawa et al., 2015). In plants, the TOR complex
plays similar roles as TORC1 in animals and fungi by inﬂuencing
cytoplasmic protein translation, carbon metabolism, cell growth,
cell proliferation, senescence, and autophagy (Deprost et al.,
2007; Liu and Bassham, 2010; Caldana et al., 2013; Xiong and
Sheen, 2015; Rexin et al., 2015). However, the speciﬁc down-
stream signaling targets and intersecting pathways with TOR
kinase in plants are still not completely understood, especially as
they relate to control of metabolism. Although the Arabidopsis
thaliana TOR gene AtTOR is essential (Menand et al., 2002),
conditional silencing resulted in early senescencewith a decrease
in photosynthesis linked to chlorophyll breakdown (Deprost et al.,
2007) along with other metabolite changes reﬂecting altered
carbonmetabolism (Deprost et al., 2007;Renet al., 2012;Caldana
etal., 2013;Rexinetal., 2015). InArabidopsis, regulationbysugars
is upstream of TOR with glucose activating TOR and promoting
cell proliferation in root meristems (Xiong et al., 2013). Overall, the
roles of TOR in controlling carbon metabolism remain relatively
unexplored in photosynthetic eukaryotes including algae where
there is a growing interest in harnessing photosynthetic metab-
olism for increased biomass accumulation or as a feedstock for
bioenergy (Hu et al., 2008; Merchant et al., 2012; Markou and
Nerantzis 2013;MayﬁeldandGolden, 2015;Scrantonet al., 2015).
In some species, including Chlamydomonas, TOR can be
inhibitedby themacrolidedrug rapamycin,whichhasproven tobe
a pivotal tool for investigating TOR signaling (Crespo et al., 2005;
Loewith and Hall, 2011; Rexin et al., 2015). Although Chlamy-
domonas is sensitive to rapamycin, at saturating drug concen-
trations cells grow slowly but do not arrest growth completely
(Crespo et al., 2005). A screen for rapamycin resistancemutations
identiﬁed alleles of FKB1 that encode an ortholog of FK506 binding
protein FKBP12 (Crespo et al., 2005; Vallon, 2005), a conserved
peptidyl prolyl isomerase that forms a ternary complex with rapa-
mycin and TORC1 and is required for rapamycin-mediated TOR
inhibition (Heitman et al., 1991; Brown et al., 1994; Sabatini et al.,
1994). Having a haploid genome and well developed molecular
genetic tools, Chlamydomonas is a promising unicellular model
organism in which to pursue functional studies of TOR kinase sig-
naling and photosynthetic growth control.
Here, we used insertional mutagenesis in Chlamydomonas to
screen for rapamycin-hypersensitive mutants. In doing so, we
identiﬁed a loss-of-function mutation in VIP1, a gene encoding
a conserved protein with predicted diphosphoinositol phosphate
kinaseactivitywhose functionhasnotpreviouslybeen linked toTOR
signaling. Levels of InsP7 and InsP8, the predicted products of VIP1
kinase, were reduced in vip1-1, suggesting that these InsPs are
required for cell growth in conjunction with TOR kinase activity.
Unexpectedly, rapamycin hypersensitivity of vip1-1 mutants re-
quired the presence of acetate in its growth media and the mutant
cellswerealso found tohavealtered levelsof tricarboxylicacid (TCA)
cycle intermediates and increased levels of neutral lipids compared
with wild-type cells. Our ﬁndings have implications for carbon
partitioning and metabolic control by TOR and InsPs in other eu-
karyotes where these signaling systems are conserved and may
provideameansofmanipulatingcarbonﬂuxand increasingyieldsof
valuable storage compounds in algae and crop plants.
RESULTS
Isolation of Rapamycin-Hypersensitive Mutants
from Chlamydomonas
A previous screen for rapamycin resistance yielded only fkb1
mutants (Crespo et al., 2005), so we instead screened for rapa-
mycin hypersensitivity among a population of insertional mutants
(Galván et al., 2007) generatedwith themarker aph799 that confers
resistance to the drug hygromycin (hygR phenotype) (Berthold
et al., 2002).We anticipated that rapamycin hypersensitivitymight
result when growth-related processes that are regulated or cor-
egulatedbyTORare impaired.Ourwild-typestrains (CC-1690and
CC-1691) and most strains that we have tested show slowed but
not completely inhibitedgrowth in thepresenceof rapamycin,with
saturation occurring at 500 nM to 1 mM (Crespo et al., 2005). We
transformed and screened around 60,000 insertional mutants in
CC-1690 for arrested or reduced growth in 500 nM rapamycin but
normal growth in its absence (Figure 1A; see Methods). After
retesting initial positives, we found only two mutants that had
a consistent rapamycin hypersensitive (rapHS) phenotype, one of
which, 266F3 (later found to be caused by insertion in the VIP1
locus and designated vip1-1), is the focus of this study.
Among600 total progeny fromabackcross toawild-typestrain,
we found consistent cosegregation of the rapHS phenotype with
the hygR insertion (Figure 1B). We next tested whether the rapHS
phenotypewasdependenton thepresenceof theFKBP12protein
encoded by FKB1. fkb1 vip1-1 double mutants were completely
insensitive to rapamycin, indicating that the rapHS phenotype in
vip1-1 results from impaired TOR kinase signaling rather than off-
target effects of rapamycin (Figure 1C). Further supporting the
speciﬁcity of the mutant phenotype was our ﬁnding that vip1-1
growth had a similar hypersensitivity to two other TOR kinase
inhibitors with different inhibitory mechanisms from rapamycin,
AZD8055 and Torin1 (Figure 1A) (Thoreen et al., 2009; Chresta
et al., 2010).
Weused adaptor-mediatedPCR to identify a simple insertionof
the HygR marker in the 11th coding exon of Cre03.g185500,
whose predicted protein is related to a family of diphosphoinositol
pentakisphosphate kinasesalsoknownasVIPproteins thatwill be
described below (Figure 1D). The 266F3 mutation in Chlamydo-
monas was therefore designated vip1-1. Vegetative diploids with
genotypes VIP1/VIP1, vip1-1/VIP1, and vip1-1/vip1-1 were con-
structed and tested to reveal that the vip1-1mutation is a loss-of-
function allele that is completely recessive to the wild-type allele
(Supplemental Figure 1).
We cloned the;11-kb wild-type VIP1 genomic locus and used it
to construct complementation vectors that contain a paromomycin
resistancemarker (ParoR) forselection (Sizovaetal.,2001)andeither
unmodiﬁed VIP1 (pVIP1) or a version of VIP1 with an N-terminally
encoded OLLAS peptide epitope tag (pOL-VIP) (Park et al., 2008)
(Figure 1D; see Methods). Among >500 control transformants of
vip1-1 using an empty vector, we never observed complementation
of the rapHS phenotype, whereas among transformants that re-
ceived either pVIP1 or pOL-VIP1, we observed restoration of wild-
type or near wild-type growth in the presence of rapamycin at a rate
of ;3%, pVIP1 (2/80) and pOL-VIP1 (15/480) (Figure 1A). In trans-
formants complementedwith pOL-VIP1, we detected a single band
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on immunoblotsprobedwithanti-OLLASantibodiesmigratingat the
predicted size of tagged VIP1 (;170 kD) (Figure 1E). The same
antibody was used in immunoﬂuorescence experiments on ﬁxed
samples to localize VIP1 primarily to the cytoplasm (Figure 1F). We
conclude that the rapHSphenotypeof vip1-1 is causedbya loss-of-
function insertionmutation that either removes or impairs a cytosol-
localized VIP1 protein.
VIP1 Encodes a Predicted Diphosphoinositol
Pentakisphosphate Kinase
The predicted Chlamydomonas VIP1 protein (CrVIP1) showed
high-scoring BLASTP similarity to a conserved family of
eukaryotic diphosphoinositol pentakisphosphate kinases of the
VIP family (Muluguetal., 2007;Desai et al., 2014;Lahaetal., 2015).
VIP proteins contain two conserved domains, an ATP_GRASP
domain (pfam 13535) that is predicted to have inositol di-
phosphate kinase activity (Mulugu et al., 2007; Fridy et al., 2007;
Lin et al., 2009; Pöhlmann et al., 2014) followed by a histidine
phosphatase domain (pfam 00328) that in CrVIP1 is interrupted
with nonconserved sequences (Figure 2A). A more thorough
search revealed a second but divergent VIP-related protein in
Chlamydomonas that we designate CrVIP2. To better un-
derstand the phylogenetic relationships betweenCrVIP1, CrVIP2,
and other eukaryotic VIP proteins, we constructed a phylogeny
using theChlamydomonasVIPputativeparalogsandadiverse set
Figure 1. Identiﬁcation of the Rapamycin-Hypersensitive Mutant vip1-1.
(A) Growth of the wild type, vip1-1, and vip1-1 complemented with epitope-tagged construct pOL-VIP1 spotted onto TAP agar plates with hygromycin
(+Hyg), 500 nM rapamycin (+rap), 500 nM Torin 1, or 500 nM AZD8055.
(B) Example of 48 random progeny from vip1-1 backcrossed to awild-type strain that were spotted onto TAP plates supplemented as in (A) and scored for
hygromycin resistance and rapamycin sensitivity.
(C) The wild type, vip1-1, and vip1-1fkb1 double mutants scored for rapamycin sensitivity as in (A) and (B).
(D)Schematic representation of theCrVIP1 locus and vip1-1 insertion. Tall rectangles represent exons. The inverted red trianglemarks thepHyg insertion in
the 11th exon. The light green shaded rectangle indicates the position of the OLLAS tag in pOL-VIP1.
(E)Upper panel is a-OLLAS immunoblot of the indicated strains shown in (A) plus vip1-1 strain transformedwith an empty vector control plasmid (pSI103).
Migration of protein molecular weight markers is indicated on the left. Lower panel shows a SDS-PAGE gel loaded the same as in the upper panels and
stained with Coomassie blue (CBB).
(F) Indirect immunoﬂuorescenceusingOLLASantibody (a-OLLAS) showingstainingof anuntaggedcontrol cell (toppanel) andOLLAS-VIPexpressingcells
from two independently derived complemented strains. Left to right are DIC images, a-OLLAS signal in green, and 49,6-diamidino-2-phenylindole (DAPI)
signal inblue.Yellowarrows indicateapical endsofcellswithﬂagella.Whitearrows labeled (p)arepyrenoidsand (n) arenuclei. Small arrowsmarkchloroplast
nucleoids. White dashed and dotted lines outline cell perimeter and cytoplasmic region stained by a-OLLAS antibody, respectively. Bars = 7.5 mm.
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of VIP homologs from other taxa (Figure 2B). Overall, the phy-
logeny matches the scenario of at least one VIP gene being
present at the base of the eukaryotic radiation and undergoing
independent paralogous duplications in several lineages, in-
cluding chlorophyte algae where the duplication was present in
the ancestor of Chlamydomonas and its multicellular relative
Volvox carteri. Additional independent duplications were found in
the land plants with evidence for at least one event in monocots
(Oryza sativa) and another in dicots (Arabidopsis) (Figure 2B;
Supplemental Data Set 1).
With the exception of InsP6 (phytic acid), which accumulates to
high levels in many plant seeds, higher order InsPs (InsP4, InsP5,
InsP7, and InsP8) are typically low abundance molecules with
diverse roles in intracellular signaling (Raboy, 2003; Barker et al.,
2009; Monserrate and York, 2010; Gillaspy, 2011; Wilson et al.,
2013; Williams et al., 2015; Livermore et al., 2016). VIP1 is pre-
dicted to pyrophosphorylate InsP6 at the 1,3 positions, generating
1PP-InsP5 (In1sP7) and possibly 1,3PP-InsP4 (InsP8) (Figure 2C)
(Lin et al., 2009). Besides VIP proteins, we identiﬁed homologs of
other inositol polyphosphate (InsP) biosynthetic enzymes in
Chlamydomonas that are predicted to carry out sequential con-
version of InsP3 to InsP4, InsP5, InsP6, InsP7, and InsP8 (Figure 2C).
We note that unlike fungi/animals/amoebae, which all contain
two distinct families of enzymes capable of producing py-
rophosphorylated inositols (IP6K/KCS1 and VIP), green algae and
land plants appear to only contain the VIP family (Williams et al.,
2015).
vip1-1 Mutants Have Defects in InsP7 and
InsP8 Accumulation
The predicted products of CrVIP1, InsP7 and InsP8, are usually the
lowest abundance InsPs in eukaryotic cells and difﬁcult to detect
(Bennett et al., 2006; Lositoet al., 2009; Linet al., 2009;Desai et al.,
2014). Sensitive in vivo labeling procedures for InsP detection
using radiolabeled 3H-inositol have been successful in other
species (Azevedo and Saiardi, 2006; Stevenson-Paulik et al.,
2006), but proved unfeasible in Chlamydomonas, which does not
take up this precursor. Furthermore, InsPs were not abundant
enough in Chlamydomonas lysates to enable utilization of elec-
trophoretic separation and staining detectionmethods that donot
require labeling (Losito et al., 2009). Therefore, we developed
a reproducible and sensitive liquid chromatography and tandem
mass spectrometry (LC-MS/MS) method for detection and dis-
crimination of different InsP species calibrated using commercial
standards and a synthetic InsP (3-deoxy-3-ﬂuoro-D-myo-inositol
1,4,5 trisphosphate [3-ﬂuoro-InsP3]), as an internal standard for
normalization (see Methods). Applying this method to InsPs pu-
riﬁed from whole-cell lysates of Chlamydomonas, we compared
proﬁles of wild-type, vip1-1, and complemented vip1-1+pOL-
VIP1 strains.
UsingLC-MS/MS,wewereable to reproduciblydetect sixmajor
InsPspecies inwild-typeextracts: InsP3, InsP4, InsP5, InsP6, InsP7,
and InsP8. Although we currently cannot discriminate between
InsP stereoisomers using ourmethod, the conserved repertoire of
predicted InsP biosynthetic enzymes in Chlamydomonas (Figure
2C) suggests that the same spectrum of InsPswill be produced in
Chlamydomonas as in plants. According to our analysis,we found
InsP6 to be themost abundant specieswhile InsP7 and InsP8were
the least abundant (Figure 3A). Moreover, vip1-1 cells had sig-
niﬁcant defects in accumulation of InsP7 and InsP8 that were
present at 20 to 30% of wild-type levels and fully or partially re-
stored in complemented strains (Figure 3A, insets). The most
abundant InsP species inChlamydomonas, InsP6, was somewhat
reduced in vip1-1, while levels of three lower order InsPs (InsP3,
InsP4, and InsP5) were not signiﬁcantly altered (Figure 3A). We
hypothesize that residual InsP7 and InsP8 detected in vip1-1 is due
to the activity of CrVIP2 (Figures 2B and 2C) whose mRNA is
expressed at <10% of the level of CrVIP1 mRNA under diurnal
growth conditions (Zones et al., 2015). Together, our data support
thepredicted roleofChlamydomonasVIP1asadiphosphoinositol
kinase whose function in InsP7 and InsP8 biosynthesis is acutely
required for cell growth when the TOR signaling pathway is im-
paired.
Impaired TOR Signaling Alters InsP Levels
Our results showed a functional interaction between TOR kinase
signaling and InsPs; however, they did not indicate whether one
signaling pathway is dependent on the other or if they both
converge on a common target(s). While tools for direct mea-
surement of TOR kinase activity (i.e., conﬁrmed phosphorylation
substrates) are not currently available for Chlamydomonas, we
could measure the impact of impaired TOR signaling on in-
tracellular InsP levels. We grew wild-type and vip1-1 cultures
under mixotrophic conditions (TAP) and measured InsPs after
rapamycin addition for 1 and 12 h. One hour is the earliest time
point when growth is measurably reduced by rapamycin, and by
12 h, wild-type cells have begun to acclimate to rapamycin, while
vip1-1mutants are still growth arrested (Figure 3B). For wild-type
cells, the responseof InsPs to rapamycin involveda transient drop
in InsP5, InsP6, InsP7, and InsP8 at 1 h, with partial recovery after
12 h (Figure 3B). On the other hand, InsP3, and to some extent
InsP4, became elevated over basal levels in thewild type after 12 h
in rapamycin (Figure3B). For rapamycin-treated vip1-1,wesawno
change in InsP3, but major reductions in other InsP species, in-
cluding InsP6 that was reduced by more than 10-fold and a near
complete absence of residual InsP7 and InsP8 (Figure 3B). Taken
together, our results show that impaired TOR signaling leads to
changes in InsP levels and suggests that InsPs are downstreamof
TOR signaling. Moreover, when TOR signaling is impaired in
vip1-1 cells, InsP7 and InsP8 become nearly undetectable and
growth arrests completely, suggesting that these InsPs may play
an essential role in cell growth. Additional studies will be required
to testwhether InsPs also act upstreamof TORkinase to inﬂuence
its activity.
Interaction between vip1-1 and TOR Signaling Is Carbon
Source Dependent
When supplemented with acetate, Chlamydomonas cells gen-
erally grow faster while simultaneously downregulating rates of
photosynthesis (Heifetz et al., 2000; Chapman et al., 2015).
Growth of vip1-1, wild-type, and complemented strains on agar
plates or in liquid media with and without acetate and rapamycin
were compared (Figure 4). While vip1-1 grew at similar rates as
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wild-type or complemented strains under both phototrophic (TP
media) and mixotrophic (TAP media) conditions without rapa-
mycin (Figures 4A, 4B, and 4D), its response to rapamycin was
acetate dependent (Figures4A, 4C, and4E). Inmediawithacetate
and rapamycin, growth of vip1-1 was completely arrested (Fig-
ures 4A and 4E) and cell viability was reduced by around 20 to
30% (Figures 4F and 4G), while wild-type and complemented
strains showed only transiently slowed growth (Figure 4E) and
also had a 20 to 30% reduction in viability (Figures 4F and 4G).
However, in media without acetate, vip1-1 responded to rapa-
mycin similarly to wild-type and to complemented strains with
slowed but not arrested growth (Figures 4A to 4C). Overall, our
data suggest that defects associated with acetate metabolism
may underlie the vip1-1 phenotype of hypersensitivity to TOR
inhibition.
vip1-1 Partially Uncouples Neutral Lipid Accumulation from
Nitrogen Starvation and Acetate Assimilation
Theeffect of acetate on vip1-1prompted us to assesswhether the
twomajor storage carbonpools inChlamydomonas, neutral lipids
and starch, were altered in the mutant. For typical wild-type
strains,NileRedstained lipidbodies aremost readily detectable in
acetate-containing media when cells have been starved for
Figure 2. Domain Structure, Phylogenetic Analysis of VIP1, and Predicted InsP Pathway in Chlamydomonas.
(A)Schematic representationCrVIP1domain structure fromN terminus (N) toC terminus (C)with kinase andhistidine phosphatase domains labeled. Below
the schematic are alignments of predicted catalytic regions of VIP family members from Chlamydomonas reinhardtii (CrVIP1 and CrVIP2), Volvox carteri
(VcVIP1),Ostreococcus tauri (OtVIP1), Arabidopsis thaliana (AtVIP1), Homo sapiens (HsVIP1), and Saccharomyces cerevisiae (ScVIP1). Asterisks indicate
predicted catalytic residues. aa, amino acids.
(B) Neighbor-joining phylogeny of VIP proteins from representatives of different eukaryotic taxa. Bootstrap values for each node from 1000 replicates are
indicated as decimal fractions. Scale bar units are substitutions per site. The alignment used to generate the phylogeny is presented in Supplemental Data
Set 1.
(C) Sequential phosphorylation of 1,3,4 InsP3 is depicted with black shaded boxes representing predicted InsP kinases, black arrows representing
phosphorylation reactions, red shaded boxes representing predicted InsP phosphatases, and red arrows representing dephosphorylation reactions.
Asterisks represent predicted stereoisomers formed by VIP1 or VIP2 (see main text for details).
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nitrogen (TAP -N) (Figure 5A). By contrast, in vip1-1 strains, we
always observed lipid bodies, even under conditionswhere fewor
no lipid bodies were detectable in wild-type cells, such as in
actively growing cultures with nitrogen-replete media (TP and
TAP) (Figure 5A). Quantitative measurements of total lipids
showed increased levels in vip1-1 strains compared with the wild
type under the same growth conditions as described above with
signiﬁcant restoration ofwild-type levels in complemented strains
(Figures 5B and 5C). Starch levels of vip1-1were not signiﬁcantly
different from wild-type strains growing in TAP, where lipid
overaccumulation was detectable (Figure 5D).
The Nile Red staining results suggested that some or all of the
excess lipids in vip1-1were triacylglycerol (TAG), themajor neutral
storage lipid form in Chlamydomonas (Wang et al., 2009; Siaut
et al., 2011; Merchant et al., 2012; Goodenough et al., 2014). To
compareTAG levels in vip1-1and thewild type,weused thin-layer
chromatography (TLC) separation and iodine staining of sepa-
rated total lipids (Figure 6A) or quantitative gas chromatography
on transesteriﬁed puriﬁed TAGs from cells grown under three
conditions: TAP (exponential phase), TAP with rapamycin (12 h),
and TAP under nitrogen starvation (TAP -N; 12 h) (Figure 6B). In
each case, we found increased TAG content in vip1-1 compared
with thewild type,suggesting that themutant iseitheradditivewith
TAG-inducing stimuli or accelerates the response to such stimuli.
While the relative distributions of acyl chain species of total lipids
fromTAP-grownwild typeandvip1-1werenotdetectablydifferent
fromeachother, the fractional compositionofacyl chainspecies in
the puriﬁed TAG fraction from vip1-1 was different from the wild
type: vip1-1 TAGs were de-enriched for C16:0 and enriched for
C16:4, C18:1, C18:2, and C18:3 (Figure 6C). C16:4 acyl chains
have been reported to be almost exclusively found in the chlo-
roplast of Chlamydomonas (Giroud et al., 1988), suggesting
adirect or indirect connection toalteredplastid lipidmetabolism in
vip1-1. Consistent with the possibility of altered chloroplast lipid
content or lipid metabolism, we found in vip1-1 an ;20% de-
crease in total galactolipids, a type that are found only in
chloroplast membranes of Chlamydomonas. By contrast, we
measured no signiﬁcant changes in phospholipids that are found
in plasma membranes and endomembranes (Giroud et al., 1988)
(Figures 6Dand6E). In summary, our data show that storage lipids
are increased in vip1-1 and that their accumulation is partially
decoupled from inducing signals such as N starvation or stress
that are required to trigger TAG accumulation in wild-type cells.
Altered TCA Metabolism in vip1-1 and Modulation of InsPs
by Carbon Source
The altered lipid accumulation phenotypes of vip1-1 suggest that
the mutant may also have underlying changes in carbon me-
tabolism. Altered metabolite levels can point to altered ﬂux in
a corresponding pathway, though they do not provide direct in-
formation on rate changes. We focused on the TCA cycle as it is
the part of central carbon metabolism most proximal to lipid
biosynthesis and to acetate utilization (Figure 7).We grew thewild
type and vip1-1with and without acetate (TAP and TPmedia) and
compared TCA metabolite levels between strains and growth
conditions. Focusing on mixotrophic conditions (TAP), we found
signiﬁcant reductions of citrate, aconitate,malate, and acetyl-coA
in vip1-1 (Figure 7, dark-blue and dark-red bars). vip1-1 cells also
responded differently from the wild type to phototrophic con-
ditions where we found 2-fold or greater increases in aconitate,
succinate, and fumarate (Figure 7, light-blue and pink bars). As
expected, wild-type cells responded to acetate with alterations in
levels of TCA cycle intermediates (Heifetz et al., 2000; Boyle and
Morgan,2009;Chapmanetal., 2015), butvip1-1doesnotundergo
the same responses, indicating potential alterations in TCA ﬂux in
this mutant that may be tied to altered lipid metabolism and its
other phenotypes.
Modulation of Intracellular InsPs in Response to Growth
Conditions and TOR Signaling
The predicted products of VIP1, InsP7, and InsP8 are potential
signaling molecules whose levels are perturbed in vip1-1 strains.
Moreover, this perturbation impacts central carbon metabolism
and lipid accumulation and appears to do so acutely when TOR
kinase signaling is also inhibited. Theseobservations suggest that
InsPs may be used in Chlamydomonas as signals for responding
Figure 3. vip1-1 Is Defective in the Production of InsP7 and InsP8.
Bar graphs scaled in arbitrary units (AU) and normalized with a standard,
3-ﬂuoro-InsP3, showing relative levels of InsP species extracted from
indicated strains and measured using mass spectrometry.
(A) Data are from the wild type, vip1-1, and two complemented strains,
vip1-1+pOL-VIP1a and vip1-1+pOL-VIP1b, growing exponentially in TAP.
Insets for InsP7 and InsP8 have magniﬁed y axis scales.
(B)Comparison of InsP proﬁles in wild-type and vip1-1 cultures growing in
TAP (0 h) or TAP treated with 500 nM rapamycin for 1 or 12 h. Error bars
indicate SD from at least three biological replicates. Asterisks represent
signiﬁcant differences (P < 0.05) evaluated using Student’s t test.
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to and/or controlling carbon metabolism. If so, the InsP proﬁles,
including the products of VIP1 (InsP7 and InsP8), would be ex-
pected to change according to growth conditions such as
presence/absence of acetate. Indeed, we found that in wild-type
cells there were signiﬁcant changes in InsPs in response to ac-
etate. Wild-type InsP3 levels were 10-fold lower in TAP versus TP,
while levels of InsP6, InsP7, and InsP8 behaved in an opposite
manner with moderately higher levels in TAP (Figure 8A). Thus,
InsPproﬁlesofwild-typecells, including thepredictedVIP1kinase
substrate (InsP6) and VIP1 kinase products (InsP7, InsP8), were
modulated by the presence and absence of external acetate.
vip1-1 cells also responded to the presence and absence of
acetate but had signiﬁcant differences fromwild-type cells. In the
case of InsP3, vip1-1 cells had near wild-type levels in acetate-
containingmedia but did not show the samedegree of elevation in
mediawithout acetate (Figure 8A). As expected, the levels of InsP7
and InsP8 in vip1-1 were severely decreased under all conditions
comparedwith thewild type.On the other hand, the levels of InsP6
were much lower in vip1-1 cells grown in TP versus TAP, while in
wild-typecells InsP6 levelschangedonlymodestlybetweenmedia
with and without acetate. In summary, InsPs in Chlamydomonas,
includingpredictedVIP1 kinase substrates andproducts, showed
Figure 4. Carbon Source-Dependent Growth Inhibition of vip1-1 by Rapamycin.
(A)Growth of the indicated strains (see Fig. 1A) spotted onto agar plates with andwithout acetate (TAP and TP, respectively) in the absence or presence of
500 nM rapamycin (+rap).
(B) to (E) Growth curves from liquid cultures of strains in (A).
(F)and (G)Viability of thewild type,vip1-1, and vip1-1+pOL-VIP1 in thepresenceandabsenceof rapamycin.Colony-formingunits (CFUs)weremeasuredat
0, 12, and 24 h and used to calculate viability (CFUs/number of cells plated). Error bars indicate SD from two biological replicates and three technical
replicates.
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complex acetate-dependent changes in accumulation proﬁles in
amanner that is consistent with InsPs acting as signals for growth
metabolism and acetate utilization. Moreover, the same set of
InsPswhose levels changedmost in response to carbon source in
wild-type cells, including InsP7 and InsP8, were the most affected
by the vip1-1 mutation. Together, our results support a role for
InsPs as intracellular signals governing carbon metabolism in
Chlamydomonas (Figure 8B).
DISCUSSION
Chlamydomonas VIP1 Provides an Entrée into Inositol
Polyphosphate Signaling in Green Algae
Higher order InsPs and the kinases that synthesize them are
largely conserved across eukaryotes (Irvine and Schell, 2001;
Raboy, 2003;Williamset al., 2015). In fungi, the roles of InsPshave
been dissected using mutants that block different steps in the
biosynthetic pathway. InsP7 and InsP8 are produced by VIP1 and/
or KCS1 kinases whose animal homologs are PP-InsP5K and
InsP6K, respectively, and play diverse roles in cell physiology,
including signaling phosphate starvation, telomere length control,
DNA repair, autophagy, environmental stress responses, cyto-
skeletal dynamics, and ribosomebiogenesis (Bennett et al., 2006;
Shears, 2009; Tsui and York, 2010; Wundenberg andMayr, 2012;
Wilson et al., 2013; Thota and Bhandari, 2015; Livermore et al.,
2016).
In plants, InsPs are of special interest because InsP6 (phytic
acid) is agronomically important as a high-abundance phosphate
storage compound in seeds (Raboy, 2003), and other InsPs have
recently been investigated for potential roles in hormone signaling
and plant defense (Tan et al., 2007; Mosblech et al., 2008, 2011;
Sheard et al., 2010; Laha et al., 2015). Green algae and land plants
encode enzymes required to successively convert InsP3 to InsP7
and InsP8 (Figure 2B) (Loewus and Murthy, 2000; Raboy, 2003;
Gillaspy, 2013; Williams et al., 2015), though they are missing the
KCS1/InsP6K family that pyrophosphorylates InsP6 or InsP7 on
Figure 5. Lipid Overaccumulation in vip1-1.
(A) Lipid bodies of strains growing in indicated media were stained with Nile Red and imaged using DIC and wide-ﬁeld ﬂuorescence microscopy with
a standard GFP/FITC ﬁlter set. All images were taken using identical microscope settings. Bars = 7.5 mm.
(B) GC-FID quantitation of total FAMEs from the wild type and vip1-1 under conditions used in (A). All values are normalized to dry cell weight. Error bars
indicate SD from three biological replicates. Asterisks represent signiﬁcant differences (P < 0.05) between means evaluated using Student’s t test.
(C)GC-FIDquantitation of total lipids in thewild type, vip1-1, and two complemented strains (vip1-1+pOL-VIP1 a andb) in TAP andTAP -N labeled as in (B).
(D) Graph of starch content of wild-type and vip1-1 strains grown in TAP and normalized by dry cell weight. Error bars indicate SD from ﬁve replicates.
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position 5 of the inositol ring, an activity which is distinct from the
activity ofVIPproteins that acton the1/3positions (Lin et al., 2009)
(Figure 2C). The two VIP paralogs of Arabidopsis (AtVIP1 and
AtVIP2; also called AtVIH1 and AtVIH2) can complement a yeast
vip1 deletion (Desai et al., 2014) and are required for jasmonate
defensesignaling (Lahaetal., 2015).AQTL for vitaminE levelsalso
mapped to one of the two Arabidopsis VIP genes (At3g01310)
(Gilliland et al., 2006), though a connection between InsPs and
vitamin E has not been directly established. Other metabolic
phenotypes in plants defective for VIP genes have not been re-
ported; however, interaction between InsP7 and SPX domain
proteins including regulators of phosphate homeostasis have
been recently found (Wild et al., 2016). We note that the media
used in our study contain excess inorganic phosphate making
phosphate metabolism unlikely to underlie the growth and met-
abolic defects we observed in vip1-1.
InsPs ingreenalgaewerepreviously examined in twospeciesof
Chlamydomonas, C. reinhardtii and C. eugametos (also called
C. moewusii), that are quite distantly related (Pröschold et al.,
2001). In both species, InsP3 appears to play a conserved role as
a second messenger and effector of cytosolic calcium inﬂux that
triggers deﬂagellation (Yueh andCrain, 1993;Quarmby andHartzell,
1994; Munnik et al., 1998) and is also linked to light-dependent
expression of GSA, a gene of the heme/chlorophyll biosynthetic
pathway (ImandBeale,2000). InsPkinaseactivities thatcanproduce
InsP4, InsP5,and InsP6havebeenfound inextracts fromC.eugametos
(Irvineetal.,1992),butnoroles for thesehigherorder InsPsorevidence
of pyrophosphorylated InsPs have been previously reported in green
algae. Our identiﬁcation of a mutation in the C. reinhardtii VIP1 gene
thatcausesdefects in InsP7andInsP8accumulationprovidesatool for
dissecting the rolesof VIPproteins and pyrophosphorylated InsPs
in green algae with possible relevance for other eukaryotic
Figure 6. Increased TAG and Decreased Galactolipids in vip1-1.
(A) TLC separation and iodine staining of different lipid classes from total lipids of wild-type and vip1-1 cells growing in TAP, TAP supplemented with
rapamycin for 12h (+rap), or transferred toTAP-N for 12h.The left-most lanecontainsamixtureof standards (Mixstd)whoseconstituentsareabbreviatedas
follows: PE, phosphatidyl ethanolamine; MAG, monoacylglycerol; DAG, diacylglycerol; FFA, free fatty acids; TAG, triacylglycerol. The identiﬁcation of
b-carotene in the fastest migrating position was done separately using a puriﬁed standard. Blue arrowhead on right indicates migration of TAGs.
(B)Quantitation of FAMESderived from puriﬁed TAGs and normalized by dry cell weight for strains shown in (A). Errors bars indicate SD from ﬁve replicates.
(C) Relative distribution (percent total) of acyl group types from TAG fraction of wild-type and vip1-1 strains.
(C) and (D) Percentage of FAMEs in galactolipid and phospholipid fractions puriﬁed from the wild type and vip1-1 and normalized by dry cell weight. Error
bars indicate SD from at least three biological replicates. Asterisks represent signiﬁcant differences (P < 0.05) between means evaluated using Student’s
t test.
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species, including plants that also contain VIP proteins but no
KCS1/InsP6K-likeproteins (Bennett et al., 2006;Desai et al., 2014;
Williams et al., 2015). Despite vip1-1 being a loss-of-function
allele, the mutants still have some detectable InsP7 and InsP8
(Figures 3 and 8), indicating that there may be another route for
InsP7 and InsP8 synthesis in these cells. A second predicted VIP
gene, VIP2 (Figures 2B and 2C), is the best candidate for pro-
ducing residual InsP7 and InsP8 in vip1-1.
InsPs as a Metabolic Signal for Carbon Metabolism
Much attention has already been focused on the metabolic
pathways of Chlamydomonas that are responsible for accumu-
lation of TAGs as these are important end products for biofuel and
biotechnology applications (Hu et al., 2008;Merchant et al., 2012;
Liu and Benning, 2013; Goodenough et al., 2014). Previous
studies have assessed the responses of metabolic genes and
proteins under non-steady state conditions when TAG accumu-
lates (Miller et al., 2010; Boyle et al., 2012; Msanne et al., 2012;
Blaby et al., 2013; Wase et al., 2014) or identiﬁedmutants that are
defective for TAG accumulation or catabolism (Li et al., 2012;
Boyle et al., 2012; Tsai et al., 2014; Xie et al., 2014; Ngan et al.,
2015; Kajikawa et al., 2015). The relationship between starch
synthesis and TAGs has also been investigated, and it appears
that ﬁxed carbon can be shunted toward TAGs when starch
synthesis is blocked (Li et al., 2010a, 2010b; Work et al., 2010;
Siautetal., 2011;Goodenoughetal., 2014).One recently identiﬁed
regulatorymutant, tar1, is defective in accumulationof lipidbodies
in response to nutrient starvation, and the TAR1 locus was shown
to encode a YAK subtype DYRK family protein kinase (Kajikawa
et al., 2015). The transcription factors PSR1 and NRR1 have also
been postulated as regulators for lipid accumulation during ni-
trogen starvation (Boyle et al., 2012; Ngan et al., 2015), and the
transcription factor CHT7 is required for TAG remobilization when
starved cells are returned to nutrient-replete media (Tsai et al.,
2014). To date, no putative regulatory mutants have been iden-
tiﬁed that uncouple TAG accumulation from nitrogen starvation or
acetate supplementation as we observed in vip1-1, nor have
regulatorymutants beendescribed that cause increasedTAGand
lipid overaccumulation compared with wild-type cells.
Figure 7. Altered Proﬁles of TCA Cycle Metabolites in vip1-1.
Diagram of TCA cycle with bar graphs showing levels of metabolites that were measured in the wild type and vip1-1 growing mixotrophically in TAP or
phototrophically in TP. Solid black arrows show the canonical respiratory TCA cycle where carbon is lost as CO2; gray dashed arrows show the glyoxylate
cycle where carbon is conserved for anabolicmetabolism. y axes aremeasured in nmol/gFW. Error bars indicate SD from at least three biological replicates.
Asterisks represent signiﬁcant differences (P < 0.05) between means evaluated using Student’s t test.
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Under mixotrophic conditions (light+acetate), vip1-1 cells
completely arrested growth in the presence of rapamycin, while in
phototrophic conditions (light only), rapamycin hypersensitivity
was relieved (Figure 4), indicating an interaction between InsPs,
TOR signaling, and carbon metabolism. Even in the absence of
rapamycin, vip1-1 mutants showed metabolic defects including
overaccumulation of TAGs that were partially uncoupled from
starvation or stress cues (Figures 5 and 6).Wepropose that InsPs,
including those produced by VIP1 kinase, are used in Chlamy-
domonas as metabolic signals that interact with the TOR kinase
signaling pathway to control growth and lipid storage in response
to the availability of organic carbon (Figure 8B). Supporting this
idea was our ﬁnding that the relative abundances of InsPs, in-
cluding the predicted VIP1 products InsP7 and InsP8, changed
signiﬁcantly in wild-type cells growing under phototrophic versus
mixotrophic conditions (Figure 8A) and their levels also responded
to TOR inhibition by rapamycin (Figure 3B). The natural diversity of
InsPs structural isomers (Irvine and Schell, 2001; Saiardi, 2012)
and their rapid turnover could make them highly responsive
signals for metabolic control.
Although vip1-1mutants do not appear to suffer from any acute
metabolic tradeoffs, there are likely to be ﬁtness defects in this
mutant that emerge under speciﬁc conditions that have not been
tested here. Importantly, the metabolic alterations in vip1-1 that
lead to increased TAG levels appear to be synergistic with other
conditions that cause increased TAG accumulation such as ni-
trogen starvation or rapamycin treatment (Figures 6A and 6B). It
remains to be determinedwhether the normal responses to stress
and starvation are accelerated in vip1-1 or if the mutant activates
a parallel pathway for storage lipid accumulation. Two recent
studies implicated the TCA pathway in carbon utilization and lipid
accumulation. A Chlamydomonas mutant missing isocitrate ly-
ase, a key enzyme in the glyoxylate shunt within the TCA cycle,
was found to have acetate-speciﬁc growth defects and to over-
accumulate lipids (Plancke et al., 2014). A metabolic modeling
study also found that changes in TCA ﬂux were required to
maintain metabolic balance when switching from phototrophic to
mixotrophic growth (Chapman et al., 2015). Our metabolite pro-
ﬁling results (Figure7) further suggest that accumulationof lipids in
vip1-1 may be coupled to altered ﬂux through the TCA cycle.
A Connection between Inositol Polyphosphates and the TOR
Signaling Pathway in Chlamydomonas Is Revealed by vip1-1
Interactions betweenTORsignaling and InsP in yeast andanimals
have been suggested by several studies (Chakraborty et al., 2010;
Kim and Guan, 2011) including roles for InsP kinases upstream
(Nagata et al., 2005) and downstream of TOR (Worley et al., 2013).
Theseﬁndingsarenotmutually exclusive, but theydohighlight the
potential complexity of intracellular signaling pathways where
feedback loops can connect signaling systems at different levels.
To date there has been no connection made between TOR sig-
naling in photosynthetic eukaryotes and InsPs. Interestingly, we
found that rapamycin inhibition, even in wild-type cells, caused
changes in InsP levels,meaning that at least part of the rapamycin
hypersensitivity we see in vip1-1 could be caused by defects in
InsPs that act as effectors of TOR signaling (Figures 3B and 8B).
Theapparently complete eliminationofdetectable InsP7and InsP8
in rapamycin-treated vip1-1 cells is suggestive of an essential role
for these InsPs in cell growth.Weattempted toassess theeffect of
vip1-1 on TOR kinase signaling using a commercial antibody that
detects S6K (ribosomal protein S6 kinase) phosphorylation by
TOR on a conserved site (Thr-389 in human S6K and Thr-932 in
Chlamydomonas) and that has been used successfully in Arabi-
dopsis (Xiong et al., 2013) but were unable to detect a speciﬁcally
recognized cross-reacting protein in Chlamydomonas extracts.
Nonconservationwith the humanS6Kphospho-epitope at the23
and25 positions with respect to T389 may be partly responsible
for this lackofcross-reactivity.Until TORkinaseactivityassaysare
developed forChlamydomonas,wecannot test thepossibility that
InsPs are also upstream of TOR signaling and/or function in
a parallel pathway (Figure 8B). While the relationships between
TOR and InsPs remain to be fully elucidated, the synergism be-
tween the two signaling systems that we uncovered may have
relevance in other eukaryotes where both are conserved.
Figure 8. TOR and InsP Interact to Control Cell Growth, Acetate Me-
tabolism, and Neutral Lipid Accumulation.
(A)Modulationof intracellular InsP levelsbycarbonsource.Graphs labeled
as in Fig. 3 showing InsP levels from thewild type and vip1-1 growing in the
presence or absence of acetate (TAP and TP, respectively).
(B) Summary ﬁgure of proposed relationships between carbon source
(acetate), TOR, and InsPs produced by VIP1. Black arrows indicate in-
teractions shown in this work (TOR signaling and carbon source inﬂuence
InsP levels), while dashedgray arrowswithquestionmarks are possibilities
that were not directly tested. TOR and the InsPs produced by VIP1 syn-
ergistically inhibit TAG accumulation (repression bar) and promote cell
growth (arrow).
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METHODS
Chlamydomonas reinhardtii Strains, Culture Conditions, and
Viability Test
Strain CC-1690 wild-type MT+ (Sager 21gr) (Sager, 1955) was used as
parental strain to generate vip1-1. CC-1691 (Sager 6145c) wild-typeMT2
was used for segregation/linkage analysis and diploid generation de-
scribedbelow.An fkb1mutant (originally named rap2) containsadisruption
in the Cre13.g586300 locus and was kindly provided by Jose-Luis Crespo
(Crespo et al., 2005). All cultures were maintained on TAP (Tris acetate
phosphate) agar plates (Harris, 2009b). TP was prepared as TAP but
omitting acetic acid and replacing Tris-base with Tris-HCl, pH 7.4. N-free
media was prepared by omitting NH4Cl. Liquid cultures were grown in
500-mL ﬂasks at 25°C in temperature controlled water baths illuminated
continuously frombelowwith;150mEm22s21LED lights (1:1ﬂuence ratio
red [625 nm] and blue [465 nm]) and bubbled with air or air enriched with
0.5% CO2 (v/v). Except where mentioned, experiments were done using
cultures inexponential phase (1 to23106cells/mL) thatweremaintained in
exponential phase through frequent dilution (at least once per day).
N-starved cultures were prepared by centrifuging and washing cells twice
in the N-freemedia (TAP-N or TP-N) and then resuspending them in N-free
media. Cultures were monitored for cell size and cell concentration using
a Multisizer 3 Coulter Counter (Beckman).
Viability experiments were performed using cultures pregrown to mid-
lateexponential phase (2 to83106cells/mL) and thendiluted into thesame
media with or without rapamycin to a density of ;2 3 105 cells/mL. Ra-
pamycin (LC Laboratories) was added to a ﬁnal concentration of 500 nM
from a 50 mM stock in DMSO. Viability for each sample was calculated by
dividing the number of colony-forming units determined by plating on agar
plates by the cell density measured in a Coulter Counter.
Mutant Screening
Insertional mutagenesis (Galván et al., 2007) with a hygromycin resistance
gene, aph799 (Berthold et al., 2002), was used to generate mutants using
wild-type parental strain CC-1690. Transformation was performed using
electroporation modiﬁed from a published method (Shimogawara et al.,
1998), as follows: 300mL cultures in TAPwere grown to a density of;13
106/mL. Cells were harvested by centrifugation (4000 rcf, 5 min, room
temperature) and resuspendedat3.53108 /mL inTAPwith50mMsorbitol.
Next, 1 mg DNA and 300 mL of the cell suspension were placed into 4-mm
cuvettes (Bio-Rad) prechilled on ice for 15 min, and then electroporated
using a GenePulser Xcell (Bio-Rad), with settings of 800 V, 25 mF, and no
resistance. Transformantswere recovered in 10mLTAP+50mMsorbitol in
low light for 16 h and then concentrated and spreadon twoTAPagar plates
supplementedwith 30mg/mLhygromycin for selection. Transforming DNA
was a 1.7-kb gel-puriﬁed aph799 expression cassette (Berthold et al., 2002)
digested fromplasmidpHyg3withHindIII (NewEnglandBiolabs). After 4 to
5 d, colonies were picked into 96-well plates containing TAP, grown to
saturation, and then pinned onto TAP and TAP + rapamycin plates. Ra-
pamycin-hypersensitive mutants were identiﬁed by comparing growth on
TAP versus TAP + 500 nM rapamycin. AZD8055 (LC Laboratories) and
Torin1 (LC Laboratories) were used at 500 nM ﬁnal concentration diluted
from a 50 mM stock in DMSO.
Genetic Analysis
Gamete preparation, mating, and segregation analyses were done as
described previously (Harris, 2009c). Random meiotic progeny isolated
from among thousands of zygote colonies were individually grown in
96-well microtiter plates andpinned onto agarmedia plates supplemented
with hygromycin or rapamycin. Mating type was scored using PCR gen-
otyping (primers presented in Supplemental Table 1) (Zamora et al., 2004).
Vegetative diploid strains (Ebersold, 1967) were generated using vip1-1
and/or wild-type parental strains of the opposite mating type transformed
with either a paromomycin resistance marker containing plasmid, pSI103
(Sizova et al., 2001) or a zeocin resistance marker containing plasmid,
pSP124S (Lumbreras et al., 1998). Gametes of opposite mating type and
containing different resistance markers were spread onto TAP agar con-
taining 20and15mg/mLzeocin shortly aftermixing (1 to 2h) andvegetative
diploid colonies were picked and conﬁrmed using PCR-based genotyping
(Supplemental Table 1) (Zamora et al., 2004).
vip1-1 Mapping and Genotyping
Ampliﬁcation of the pHYG3 insertion junction was performed according to
a previously described strategy (O’Malley et al., 2007) using genomic DNA
prepared as described (Umen and Goodenough, 2001). Genomic DNA
from 266F3 was digested with PvuII, SmaI, StuI, and PmlI and blunt-end
ligated to annealed adaptor oligonucleotides (Supplemental Table 1).
Junction fragments were ampliﬁed using nested reactions with adaptor
primers AP1 and AP2 along with IMPh5-1 and IMPh5-2, or with IMPh3-1
and IMPh3-2 (Supplemental Table 1). Cloned junction fragments were
sequenced and the left border conﬁrmed by amplifying and sequencing
a 426-bp fragment ampliﬁedwith IMPVIP3F and IMPVIP3R (Supplemental
Figure 1 and Supplemental Table 1).
Genotyping was done using 0.5 mL of total genomic DNA prepared
using a fast method described at http://www.chlamycollection.org/
methods/quick-and-easy-genomic-dna-prep-for-pcr-analysis/. The VIP1
wild-type allelewas scored using VIPWTL andVIP1WTR (Supplemental
Figure 1 and Supplemental Table 1), and the vip1-1 allele was scored
usingVIPWTLand IMPVIPR.PCRwasperformedusing Taqpolymerase
in a ﬁnal reaction volume of 20 mL in the presence of 13 Taq buffer
(Sambrook and Russell, 2001), 1 mM primers, 80 mM dNTP, 2%DMSO,
and 0.5 mL of genomic DNA. PCR conditions were as follows: 96°C for
2min and then35cycles of 94°C for 30 s, 60°C for 30 s, and72°C for 30 s.
RNA extraction, cDNA synthesis, and RT-PCR were performed as
previously described (Fang and Umen, 2008). VIP1WTL and VIP1WTR
(Supplemental Figure 1 and Supplemental Table 1) were used to amplify
cDNAs from theVIP1 locus in the ﬂanking regionwhere pHYG is inserted in
vip1-1 (Supplemental Figure 1). PCR conditions were the same as above.
Cloning and Epitope Tagging of CrVIP1
Chlamydomonas BAC clone 4C23 (Kim et al., 1996) (http://www.genome.
clemson.edu) was digested with PsiI and EcoRI and a 14628-bp fragment
containing VIP1was gel puriﬁed. The VIP1 fragment was ligated to pSI103
(Sizova et al., 2001) digested with SmaI and EcoRI to generate pVIP1. An
OLLASepitope (Park et al., 2008) was inserted into theN terminus of pVIP1
as follows. Two fragments (A and B) were ampliﬁed from VIP1, fragment A
with primers OLLVIP1F and OLLVIP1R, and fragment B with primers
OLLVIP2F and OLLVIP2R (Supplemental Table 1). OLLVIP1R and
OLLVIP2F share an overlapping sequence that encodes the OLLAS tag
sequence (Supplemental Table 1, underlined) and homology with VIP1.
Both fragments were ampliﬁed using Taq polymerase as described above.
pVIP1 and fragments A and B were digested with PfoI (Thermo Scientiﬁc)
(Supplemental Table 1, lowercase) and recombined using an In-Fusion HD
Cloning Kit (Clontech) according to the manufacturer’s instructions to
generate pOLLAS-VIP1.
Complementation of vip1-1
vip1-1 was transformed by electroporation as described above and col-
onies were selected on TAP plates containing 30 mg/mL paromomycin.
Transformants were picked and grown in 96-well plates in TAP until
growth saturation and then they were pinned onto TAP containing
500 nM rapamycin. Positive clones were identiﬁed by loss of rapamycin
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hypersensitivity with growth rates comparable to wild-type strains on rapa-
mycin-containingplates.Complementationrateswerecalculatedafter testing
paromomycin resistant colonies in rapamycin-containing media. Comple-
mentation rates were 15/480 for pOL-VIP1 and 2/80 for pVIP1.
Immunoblotting OLLAS-VIP
Protein extraction and immunoblotting to detect pOLLAS-VIP1 were
performed as described previously (Olson et al., 2010) with the following
modiﬁcations. Total protein loaded per well was 40 mg; rat a-OLLAS an-
tibodies (NBP1-06713; Novus Biologicals; Lot A) were used at 1:1000 and
HRP-conjugated secondary a-rat antibodies (Thermo Fisher Scientiﬁc;
31470) were used at 1:4000.
InsP Extraction and Analysis
The method described below allows separation and relative quantitation
of InsP mass isomers InsP3, InsP4, InsP5, InsP6, InsP7, and InsP8. We
cannot currently differentiate between InsP stereoisomers, but meth-
odology todosousingmassspectrometry isunder development. For InsP
extraction, 300 mL of mid-log phase culture per sample was collected at
a cell density of ;2 3 106 cells/mL. (Cell density) 3 (mean cell size)
measured using a Beckman-Coulter Multisizer3 was used as a metric for
wet biomass. Sample volumeswere adjusted slightly where necessary so
that all replicates had identical wet biomasses. After harvesting by cen-
trifugation (4000 rcf, 5 min, room temperature), cell pellets were re-
suspended in 1 mL ﬁnal volume 5% trichloroacetic acid to extract InsPs
and ﬂash frozen in liquid nitrogen. After thawing, the samples were
centrifuged at maximum speed for 20 min in a microfuge at 4°C. Each
supernatant was then supplemented with 100 mL of 1 mM 3-ﬂuoro-InsP3
(3-deoxy-3-ﬂuoro-D-myo-inositol 1,4,5-trisphosphate) (Enzo Life Scien-
ces),which served as an internal standard for normalization. Supernatants
were extracted three timeswith 2mL ofwater-saturated diethyl ether. The
pooled aqueous phase from the extractions was loaded onto a Strata-X
AW column (Phenomenex; 30 mg resin; weak anion mixed mode phase
33-mmparticle size). The columnwaswashedwith 1mL of 25%methanol
to remove trichloroacetic acid and other contaminants and the InsP were
elutedusing1mLof 100mMammoniumcarbonate. Then, 0.5mLof acetic
acidwas added to each eluate and the sampleswere vacuum-dried. Each
samplewasresuspended in50mLofultrapurewater justprior toLC-MS/MS
analysis. The ﬁnal LC-MS/MS injection volume was 8 mL.
LC-MS/MS data were acquired using a Q-Exactive mass spectrometer
(Thermo Fisher Scientiﬁc) equipped with a 1200 Capillary LC system
(Agilent) and a 0.5 3 150-mm 5-mm BioBasic AX Column (Thermo Fisher
Scientiﬁc)usingchromatographic conditionsadapted fromLiuet al. (2009).
The solvents were 250 mM ammonium carbonate (A) and 25% methanol
(B). The gradient consisted of a hold for 4 min at 100% B, then a ramp to
10%A over 6min, then up to 60%A in 7min, and ﬁnally a ramp to 100%A
over 3min, followedby ahold at 100%A for 4min. The solvent composition
was returned to 100% B over 6 min and the column was reequilibrated for
40 min for a total per sample run time of 70 min. Mass spectrometric data
were collected in negative ion proﬁle mode at a resolution of 70,000 (atm/z
200) with a full scan fromm/z 190 to 850 and SIM scans of 483.9 to 513.9,
563.9 to 593.9, 643.9 to 673.9, 723.9 to 753.8, and 803.9 to 833.8. Data
were analyzed using the QualBrowser and QuanBrowser applications of
Xcalibur (ThermoFisher Scientiﬁc). Datawere normalizedusing the internal
standard 3-ﬂuoro-InsP3. Mean data and SD were calculated from three
biological replicates, each of which had three technical replicates.
Metabolite Analysis
Mid-log phase (;2 3 106 mL21) cultures were harvested by fast vacuum
ﬁltering onto 50-mm Whatman ﬁlter paper (GE Healthcare Life Sciences;
1822-050), which was immediately quenched in liquid nitrogen with the
total processing time foreachsamplekeptunder10s.Freshweight (FW) for
each sample was calculated by determining wet biomass volume (culture
density3mean cell size3 volume harvested). Packed cells have a density
close to 1 mg/mL; therefore, FW in milligrams was equivalent to pellet
volume in milliliters. Polar metabolites in frozen samples (5 to 8 mg FW)
were extracted with methanol/chloroform/water (7:3:5.6) and analyzed via
LC-MS/MS as previously described (Ma et al., 2014) with 0.3 nmole PIPES
added to each sample as an internal standard. Metabolite concentrations
(nmol gFW21) were determined by interpolating from the linear relationship
between peak area and the concentrations of standards.
Lipid Analysis
Gas Chromatography-Flame Ionization Detection
Total lipid extraction and fatty acid methyl esters (FAMEs) were obtained
from 5 mg of Chlamydomonas freeze-dried pellets using the method re-
ported in Han et al. (2010) and using triheptadecanoin (C17:0 TAG) as an
internal standard (Nu-ChekPrep).After evaporationundernitrogengas, the
samples were resuspended in 200 mL hexane and 1 mL was separated by
Trace-GC with an FID detector (Thermo Fisher Scientiﬁc) ﬁtted with an
HP-INNOWax column (0.25-mm inner diameter and 30-m length) (Agilent).
The oven temperature was programmed to 100°C (hold 1 min) to 235°C
(hold 5min) in a ﬁrst ramp of 40°C/min until 185°C and then a second ramp
of 7.5°C/min to 235°C. Peak assignments weremade using FAMEmixC8-
C22 (Supelco) and the double-bond positions of the polyunsaturated
fatty acidswere conﬁrmed by gas chromatography-mass spectrometry
(Cahoon et al., 2006).
TLC
Twenty milligrams of freeze-dried pellet was used for extraction of total
lipids using a modiﬁcation of the standard Bligh and Dyer method (Bligh
andDyer, 1959). Fourmilliliters of CHCl3:methanol (2:1) was added to the
sample that was then mixed by vortexing. The samples were heated at
42°C for 30 min followed by addition of 2.5 mL 0.1 N HCL:1 M NaCl and
additional mixing by vortexing. Samples were centrifuged for 2 min at
500 rcf at room temperature and then the aqueous (upper) phase was
discarded. Theorganic phasewaswashed twicewith ultrapurewater and
then dried under nitrogen gas. Samples were resuspended in 1 mL
hexane and split into three equal (333 mL) parts. One part was trans-
methylated to FAMEs and analyzed by gas chromatography-ﬂame
ionization detection (GC-FID) as described above. A second part was
used for TLC separation as described by Han et al. (2010) with image
acquisition using an Alphaimager 2200 (AlphaInnotec). A mixture of
standards was prepared using 18:1 free fatty acid, 18:1 triacylglycerol
(TAG), 16:0/18:1 diacylglycerol, and 18:1 monoacylglycerol, 30 mg each,
in 200 mL hexane. The third part was used for TAG separation on a silicic
acid column with Iatrobeads of 0.5-cm internal diameter (Mitusbishi
Kagaku Iatron). Columns were prepared using disposable glass Pasteur
pipettes stopped with untreated glass wool and exactly 2 cm of beads.
Columns were equilibrated with 4 mL hexane and then 200 mL of sample
was loaded onto the column and TAGs were eluted with 4 mL of chlo-
roform. Galactolipids and phospholipids were then eluted using 4 mL of
acetane and methanol, respectively. After elution, all the fractions were
dried and redissolved in hexane followed by fractionation on TLC plates
or analysis by GC-FID, as described above.
Starch Analysis
StarchwasmeasuredusingaTotal StarchAssayKit (AA/AMG;Megazyme)
following the manufacturer’s instructions, but scaled down to 10 mg
freeze-dried cell powder as starting material. Mean and SD were calculated
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Lipid body staining was performed as described (Wang et al., 2009). Mi-
croscopywasperformedwithaLeicaDMI6000Businga633oil immersion
objective with differential interference contrast (DIC) optics or wide-ﬁeld
ﬂuorescence collected using a Leica L5 ﬁlter cube (excitation BP 480/40;
dichroic 505; emission BP 527/30).
Immunoﬂuorescence
Immunoﬂuorescence was performed as described previously (Olson et al.,
2010) with the followingmodiﬁcations. Primary rat a-OLLAS antibody (NBP1-
06713, Lot A; Novus Biologicals) was used at 1:100 and secondary a-mouse
(Alexa Fluor 488, A-11001, Lot 99C2-2; Thermo Fisher Scientiﬁc) was used at
1:1000, as recommended by the manufacturer. Microscopy was performed
with aLeicaDMI6000Businga1003oil objective lenswithDICopticsor using
the following ﬁlter cube sets A4: excitation BP 360/40; dichroic 400; emission
BP470/40, L5: excitation BP 480/40; dichroic 505; emission BP 527/30.
Z stacks through the entire cell were collected for each image (203 0.2 mm).
Phylogenetic Tree Construction
Accession numbers for VIP1 homolog protein sequences used for align-
mentandtreeconstructionare listedbelow.MEGA(Tamuraetal., 2013)was
used for all tree building steps. Sequences were aligned using MUSCLE
(Edgar, 2004).All positionscontaininggapsandmissingdatawere removed
and an unrooted neighbor-joining tree was constructed using the JTT
distance model with gamma set to 0.8 and 1000 bootstrap replicates.
Accession Numbers
Sequence data from this article can be found for Chlamydomonas genes in
Phytozome (https://phytozome.jgi.doe.gov/pz/portal.html) under the follow-
inggene IDs:FKB1,Cre13.g586300;CrVIP1, Cre03.g185500;CrVIP2,Cre01.
g052650; CrITPK1, Cre03.g182100; CrITPK2, Cre01.g018400; CrIPMK,
Cre12.g555450; CrIP5-2K, Cre04.g229000; and CrDIPP, Cre02.g106500.
The remainingsequencescanbefoundatNCBIProteindatabaseorGenBank
(http://www.ncbi.nlm.nih.gov). Protein database accession numbers are as
follows: Volvox carteri VcVIP1: XP_002948572.1, VcVIP2 XP_002946745.1,
Coccomyxa subellipsoidea CsVIP1: XP_005644985.1; Micromonas pusilla
MpVIP1: XP_003058868.1; Ostreococcus tauri OtVIP1; XP_003078214.1,
Ostreococcus lucimarinus OlVIP1: XP_001416675; Oryza sativa
OsVIP2: NP_001050945; Arabidopsis thaliana AtVIP1: NP_186780.3 and
AtVip2: NP_001190313.1; Homo sapiens HsVIP1: NP_001124330.1 and
HsVIP2: NP_001263206; Thalassiosira pseudonana CCMP1335 TpVIP1:
XP_002288041.1; Phaeodactylum tricornutum CCAP 1055/1 PtVIP1:
XP_002185836.1;UstilagomaydisUmVIP1: XP_011392692.1;Aspergillus
nidulansFGSCA4AnVIP1: XP_663401.1;Caenorhabditis elegansCeVIP1:
NP_740855.2; Schizosacharomyces pombe SpVIP1: NP_587877.1;
Saccharomyces cerevisiae ScVIP1: NP_013514; GenBank: Oryza sativa
OsVIP1: EEE55479.1; Drosophila melanogaster DmVIP1: AAT94524.1.
Supplemental Data
Supplemental Figure 1. vip1-1 insertion structure, genotyping, and
dominance testing.
Supplemental Table 1. Sequence of primers used for mapping and
genotyping VIP1 or vip1-1 and for constructing pOL-VIP1.
Supplemental Data Set 1. Alignment used to generate the phylogeny
presented in Figure 2B.
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